Gradient

Recent Scientific Papers

In addition to the searchable list below, Gradient offers two of its own publications through the full website. Trends focuses on issues in environmental risk science and EH&S Nano News focuses on the latest in nanotechnology.


Showing Results for: "Hixon"

Hixon, ML. 2019

Teratogenesis.

In Toxicology Principles for the Industrial Hygienist (Second Edition). (Eds.: Luttrell, WE; Still, KR; Church, JA; Beyer, LA), American Industrial Hygiene Association, Falls Church, VA

Beyer, LA; Hixon, ML; Kerper, LE. 2018

A Safety Analysis of an Energy Drink.

Presented at the Society of Toxicology (SOT) 57th Annual Meeting, San Antonio, TX, March 11-15

Goodman, JE; Peterson, MK; Hixon, ML; Pacheco Shubin, S. 2018

Derivation of a Maximum Allowable Dose Level for Bisphenol A.

Presented at the Society of Toxicology (SOT) 57th Annual Meeting, San Antonio, TX, March 11-15

Beyer, LA; Hixon, ML. 2018

Review of animal studies on the cardiovascular effects of caffeine.

Food Chem. Toxicol. 118:566-571.

Hixon, ML. 2018

Assessing Lead Exposure Risk from Botanicals: Ayurvedics as a Case Study.

Presented at the Teratology Society's 58th Annual Meeting, Clearwater, FL

Hixon, M. 2017

Evaluation of Reproductive Health Effects for the Caffeine in an Energy Shot.

Presented at the Society of Toxicology (SOT) 56th Annual Meeting, Baltimore, MD

Goodman, JE; Peterson, MK; Hixon, ML; Pacheco Shubin, S. 2017

Derivation of an oral maximum allowable dose level for bisphenol A.

Regul. Toxicol. Pharmacol. 86:312-318.

Beyer, LA; Hixon, ML; Mayfield, DB; Peterson, MK; Dube, EM. 2016

Development of a Noncancer Toxicity Criterion for Triethylene Glycol (TEG) Using Developmental Toxicity Data as the Most Sensitive Endpoint.

Presented at the Society of Toxicology (SOT) 55th Annual Meeting, New Orleans, LA, March 13-17

Hixon, MM; Beyer, L. 2016

Evaluation of Reproductive Health Effects for the Caffeine in an Energy Drink.

Presented at the Teratology Society 56th Annual Meeting, San Antonio, TX, June 25-29

Beyer, L; Hixon, ML; Kerper, L. 2016

Caffeine in Energy Drinks: How Safe Is It?

Presented at the Society for Risk Analysis (SRA) Annual Meeting, San Diego, CA

Hixon, ML. 2015

Toxic effects on reproduction.

In Principles of Toxicology: Environmental and Industrial Applications (Third Edition). (Eds.: Roberts, SM; James, RC; Williams, PL), John Wiley & Sons, Inc., Hoboken, NJ

Hixon, M; Mayfield, D; Peterson, M; Dube, EM; Beyer, L. 2015

Development of a Noncancer Toxicity Criterion Using Developmental Toxicity Data as the Most Sensitive Endpoint in Estimating Health Risk(s) from TEG-Contaminated Coffee.

Presented at the 55th Teratology Annual Meeting, Montreal, Qubec, June 27-July 1

Beyer, L; Hixon, ML; Mayfield, DB; Peterson, MK; Dube, EM. 2015

Risk Assessment of Contaminated Coffee to Determine the Need for a Product Recall.

Presented at Institute of Food Technologists (IFT) Annual Meeting, Chicago, IL, July 11-14

Lemay, JC; Prueitt, RL; Hixon, ML; Goodman, JE. 2013

Distinguishing Between Risks and Hazards: A Case Study of Bisphenol A.

Presented at the Society for Risk Analysis Annual Meeting, Baltimore, MD, December 10

Moyer, B; Hixon, ML. 2012

Reproductive effects in F1 adult females exposed in utero to moderate to high doses of mono-2-ethylhexylphthalate (MEHP).

Reprod. Toxicol. 34:43-50.

LaRocca, J; Boyajian, A; Brown, C; Smith, SS; Hixon, M. 2011

Effects of in utero exposure to bisphenol A or diethylstilbestrol on the adult male reproductive system.

Birth Defects Res. B Dev. Reprod. Toxicol. 92:526-533.

Knudsen, TB; Kavlock, RJ; Daston, GP; Stedman, D; Hixon, M; Kim, JH. 2011

Developmental toxicity testing for safety assessment: New approaches and technologies.

Birth Defects Res. B Dev. Reprod. Toxicol. 92:413-420.

LaRocca, J; Pietruska, J; Hixon, M. 2011

Akt1 is essential for postnatal mammary gland development, function, and the expression of Btn1a1.

PLoS ONE 6:e24432.

Rasoulpour, T; DiPalma, K; Kolvek, B; Hixon, M. 2006

Akt1 suppresses radiation-induced germ cell apoptosis in vivo.

Endocrinology 147:4213-4221.